MedTrace Logo

Immunological Mechanisms of Rejection in Uterine Transplantation

NCT04615221 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-09-12

No results posted yet for this study

Summary

The objective of this study is to understand the mechanisms of rejection in uterine transplantation and to search for non-invasive markers of rejection. The biological samples necessary for our research have been or will be collected during procedures (biopsies, smears, vaginal swab, blood tests) carried out as part of the scheduled follow-up of patients. These will be samples whose collection is minimally or not invasive

Conditions

  • Transplant Rejection

Interventions

OTHER

Specimens

Specimens (blood, biopsy, cervical smear, vaginal swab)

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Jean-Marc Ayoubi, MD, PhD · Hopital Foch

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-21
Primary Completion
2027-09-30
Completion
2033-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04615221 on ClinicalTrials.gov